Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,944 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00320190 | Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib | terminated | Phase 2 | 52 | Bristol-Myers SquibbINDUSTRY | 11 | Oct 30, 2013 | clinicaltrials |
| NCT01361191 | Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma(R-MEGACHOP) | completed | Phase 2 | 71 | Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaOTHER |
| 1 |
| Oct 30, 2013 |
| clinicaltrials |
| NCT01795352 | Retrospective Study in a NSCLC M+ p(Ca_Pulmon) | completed | — | 187 | AstraZenecaINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT01205737 | A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects | completed | Phase 1 | 186 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 10 | Oct 22, 2013 | clinicaltrials |
| NCT00243347 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 2 | Oct 17, 2013 | clinicaltrials |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | completed | Phase 3 | 1,106 | Novartis PharmaceuticalsINDUSTRY | 16 | Oct 14, 2013 | clinicaltrials |
| NCT00392808 | Immunogenicity of the Booster Dose of Two MenC Vaccines(CSISP-MENC1) | completed | Phase 4 | 389 | Centro Superior de Investigación en Salud PublicaOTHER_GOV | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | completed | Phase 2 | 46 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT01185262 | Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia(LLC-LENAR-08) | completed | Phase 1 | 25 | MD Anderson International Spain SAOTHER | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01147939 | Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)(CLAVELA) | completed | Phase 3 | 381 | Clavis PharmaINDUSTRY | 13 | Sep 27, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT00652158 | A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies | terminated | Phase 1 | 44 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT01258816 | The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) | completed | Phase 1 | 43 | Clavis PharmaINDUSTRY | 2 | Sep 23, 2013 | clinicaltrials |
| NCT00281918 | Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia(CLL-8) | completed | Phase 3 | 817 | Hoffmann-La RocheINDUSTRY | 11 | Sep 19, 2013 | clinicaltrials |
| NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 6 | Sep 18, 2013 | clinicaltrials |
| NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | completed | Phase 3 | 450 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00004921 | High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | completed | Phase 3 | — | EBMT Solid Tumors Working PartyOTHER | 9 | Sep 17, 2013 | clinicaltrials |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 3 | 460 | EBMT Solid Tumors Working PartyOTHER | 17 | Sep 17, 2013 | clinicaltrials |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00395070 | A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | completed | Phase 3 | 390 | VicalINDUSTRY | 14 | Sep 13, 2013 | clinicaltrials |
| NCT00475293 | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC | completed | Phase 2 | 85 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Sep 13, 2013 | clinicaltrials |
| NCT01338753 | Study to Evaluate Markers of Response in Locally Advanced Breast Cancer(IMAGING) | completed | Phase 2 | 74 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Sep 10, 2013 | clinicaltrials |
| NCT00263822 | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer | completed | Phase 3 | 835 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Aug 27, 2013 | clinicaltrials |
| NCT00003122 | Surgery in Treating Patients With Neuroblastoma | unknown | Phase 2 | 210 | Societe Internationale d'Oncologie PediatriqueOTHER | 8 | Aug 26, 2013 | clinicaltrials |
| NCT00004224 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | completed | Phase 2 | 65 | Societe Internationale d'Oncologie PediatriqueOTHER | 7 | Aug 26, 2013 | clinicaltrials |
| NCT00321633 | Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer | completed | Phase 2 | 148 | University College London HospitalsOTHER | 6 | Aug 26, 2013 | clinicaltrials |
| NCT01127841 | Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line | unknown | Phase 2 | 60 | Grupo Oncológico para el Tratamiento y el Estudio de los LinfomasOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00753688 | Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy(PALETTE) | completed | Phase 3 | 369 | GlaxoSmithKlineINDUSTRY | 13 | Aug 22, 2013 | clinicaltrials |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 34 | Aug 21, 2013 | clinicaltrials |
| NCT00334854 | Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | unknown | Phase 3 | 250 | European Paediatric Soft Tissue Sarcoma Study GroupOTHER | 9 | Aug 12, 2013 | clinicaltrials |
| NCT00379457 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | unknown | Phase 3 | 600 | European Paediatric Soft Tissue Sarcoma Study GroupOTHER | 8 | Aug 12, 2013 | clinicaltrials |
| NCT00931450 | Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 1 / Phase 2 | 70 | Institut Català d'OncologiaOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01295463 | Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer | unknown | — | 96 | Institut Català d'OncologiaOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01118039 | Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer | unknown | Phase 2 | 41 | Hospital del MarOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00005583 | Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | completed | Phase 3 | 400 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 11 | Aug 2, 2013 | clinicaltrials |
| NCT01690871 | A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00480363 | QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression(QUIREDEX) | completed | Phase 3 | 120 | PETHEMA FoundationOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT01041040 | LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) | completed | Phase 4 | 200 | PETHEMA FoundationOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00690430 | Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease | completed | Phase 3 | 186 | Novartis PharmaceuticalsINDUSTRY | 16 | Jul 30, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT01698645 | Patient Satisfaction and Quality of Life Impact - PecFent®(Qualipec) | unknown | — | 150 | Archimedes Development LtdINDUSTRY | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01320020 | A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients | terminated | Phase 1 | 16 | Neovii BiotechINDUSTRY | 3 | Jul 2, 2013 | clinicaltrials |
| NCT00398333 | Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients | terminated | Phase 4 | 13 | Hospital Clinic of BarcelonaOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials